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CorticosteroneThe putative estrogen receptor GPER1 (the former orphan receptor GPR30) is discussed to be involved in
emotional and cognitive functions and stress control. We recently described the induction of anxiety-like effects
by theGPER1 agonist G-1 upon systemic injection intomice. To contribute to a better understanding of the role of
GPER1 in anxiety and stress, we investigated germ-line GPER1 deﬁcient mice.
Our experiments revealed marked differences between the sexes. A mild but consistent phenotype of increased
exploratory drive was observed in the home cage, the elevated plus maze and the light–dark choice test in male
GPER1 KO mice. In contrast, female GPER1-KO mice displayed a less pronounced phenotype in these tests.
Estrous-stage dependent mild anxiolytic-like effects were observed solely in the open ﬁeld test. Notably, we
observed a strong shift in acute stress coping behavior in the tail suspension test and basal corticosterone levels
in different phases of the estrous cycle in female GPER1-KO mice.
Our data, in line with previous reports, suggest that GPER1 is involved in anxiety and stress control. Surprisingly,
its effects appear to be stronger in male than female mice.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Introduction
Mood disorders are the most prevalent cause of morbidity and dis-
ability worldwide. The prevalence of depression and anxiety disorders
is higher in females than in males. Women are more likely to develop
generalized anxiety disorders (7% in women, 4% in men), panic disor-
ders (8% in women, 3% in men) and posttraumatic stress disorders
(12.5% in women, 6% in men) (for a review see Lebron-Milad and
Milad, 2012). These differences manifest after puberty (for a review
see Hayward and Sanborn, 2002), indicating the importance of sexual
hormones. A close interaction between mood and hormonal variations
may occur during the menstrual cycle by virtue of the cyclic modiﬁca-
tions in the synthesis, release and circulating concentrations of gonadal
steroids. Although the role of estrogen in cycle dependent mood disor-
ders like premenstrual syndrome or postpartum and menopausal de-
pressive disorders is not entirely clear (Payne, 2003; Westberg and
Eriksson, 2008), a broad range of interactions with neuronal signaling
has been demonstrated (Wittmann et al., 2009). In most humans, high
and constant levels of estrogen are described as anxiolytic and “emo-
tionally positive”. In contrast, low and/or ﬂuctuating levels correlate
with dysphoric emotional states and increased anxiety.: +43 512 9003 73200.
chwarzer).
c. This is an open access article underBesides humans, anxiogenic and dysphoric effects of estrogen (E2)
have also been described in mice, especially with ﬂuctuating levels
(Morgan and Pfaff, 2001). The dependence of behavior on the estrus
cycle has also been described in rodents (for a review see ter Horst
et al., 2012).
The best understood E2 signaling pathways are via the nuclear E2
receptors ERα and ERβ, both ligand-activated transcription factors
(Heldring et al., 2007). They primarily regulate transcription by binding
to estrogen responsive elements after translocation to the nucleus.
Nuclear estrogen receptors most probably are responsible for lasting
effects of single pulse E2 treatment (Otto et al., 2012). However, some
E2 effects reﬂect rapid changes in neuronal function by processes initi-
ated at the membrane surface (Boulware and Mermelstein, 2005).
Such membrane estrogen receptors were considered to be membrane
subpopulations of ERα and ERβ (mERα, mERβ) until the identiﬁcation
of G-protein coupled estrogen receptors. Since 2005 it has been
suggested that E2 also binds to and signals through GPER1 (the former
orphan receptor GPR30) in vitro, leading to classiﬁcation of GPER1 by
the International Union of Pharmacology as a membrane estrogen
receptor (Olde and Leeb-Lundberg, 2009). However, the function of
GPER1 as an estrogen receptor is still highly controversial (Langer
et al., 2010).
The identiﬁcation of GPER1 has introduced an additional receptor
potentially responsible for non-genomic estrogen signaling. GPER1 has
been reported to signal via Gs proteins, stimulating cAMP production,
and through a pertussis toxin-sensitive G-protein, triggering cleavagethe CC BY license (http://creativecommons.org/licenses/by/3.0/).
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ing to transactivation of EGF receptors, intracellular Ca2+ mobilization,
ERK1/2 activation, and Src activation (Olde and Leeb-Lundberg, 2009).
Both male and female rodents express GPER1 in the brain (for a re-
view see Brinton et al., 2008), with high expression in the islands of
calleja and the striatum. GPER1 has also been observed in the hypothal-
amus (Xu et al., 2009), the pituitary (Hazell et al., 2009), the hippocam-
pal formation, the substantia nigra, the PVN, the basolateral amygdala
(Tian et al., 2013) and the supraoptic nucleus (Brailoiu et al., 2007).
The localization of GPER1 in the amygdala, hypothalamus and pituitary
suggests a role in emotional control and regulation of endocrine
responses. Moreover, GPER1 expression in cholinergic neurons of the
basal forebrain suggests a role in cognitive functions (Hammond and
Gibbs, 2011).
Recently, GPER1 was suggested to play roles in E2-mediated effects
on mood, as G15 (a GPER1-selective antagonist) attenuated the effects
of G1 (GPER1 selective agonist) and E2 in a mouse model of depression
(Dennis et al., 2009), and in cognitive functions such as spatial learning,
memory and attention (for review see (Hammond and Gibbs, 2011)).
We recently identiﬁed GPER1 as a potential mediator of anxiogenic E2
effects in both male and female mice by applying pharmacological
tools (Kastenberger et al., 2012b).
However, opinions differ as to whether GPER1 mediates anxiogenic
or anxiolytic effects and how itmay affect stress related responses based
on pharmacological experiments. We now address this question in
GPER1-KOmice. Themain aim of this studywas to investigate the func-
tional role of GPER1 on anxiety and stress coping in both male and
female mice. Therefore, we compared anxiety and stress coping
behaviors of intact male and femaleWT and GPER1-KOmice in a bat-
tery of tests. Female mice were investigated with respect to their es-
trous cycle stage and also subjected to analysis of corticosterone
serum levels.
Material and methods
Mice
GPR30-deﬁcient mice were obtained from Bayer Pharma AG (Otto
et al., 2009). KO mice were backcrossed to C57BL/6J mice obtained
from Charles River (Sulzfeld, Germany). Littermates were used as con-
trols. A total of 50 wild-type and 50 KO mice were investigated in this
study. The genotype was determined by PCR analysis of genomic DNA
from tail-tip biopsies.
Agematchedmale and femalemice aged three to eightmonthswere
tested in all experiments. All procedures involving animals were
approved by the Austrian Animal Experimentation Ethics Board and
were performed in compliance with the European Convention for the
Protection of Vertebrate Animals used for Experimental and Other
Scientiﬁc Purposes (ETS no. 123). Every effort was taken to minimize
the number of animals used.
Housing conditions
Male and female mice were kept in the same room but in separate,
single ventilated cages (type 2 L), in groups of up to ﬁve mice
per cage. Mice were kept under controlled conditions (temperature
23 °C, relative humidity of approx. 45%) with lights on (50–60 lx) at
6:30 a.m. and lights off at 6:30 p.m. with free access to food and water
(tap water). The cages were bedded with wood chips and a plastic
tube as a hiding place.
Physical exam
Mice underwent a general observation to see if the eyes, whiskers,
coat and general movement were normal or altered (Karl et al., 2003).
Motor activity and circadian rhythm was analyzed for 3 days usinginfrared detection in their home cages. That was followed by a noise-
reaction-test where the mouse should respond to clapping hands with
general muscle contraction, eye blinks and retreating away from the
source of sound. Normal functioning of the whiskers was conﬁrmed
by touching the whiskers with a thin wire. Muscular strength was ana-
lyzed by the wire hang test, in which the mouse had to hang on a cage
lid, elevated 30 cm above the cage, for at least 2 min.Behavioral testing
All mice were acclimatized to the behavioral facility at least
over night in the anteroom of the testing facility before each test.
Temperature, humidity and light conditions were set as in the animal
housewith free access to food andwater. Tests were performed accord-
ing recommendations of Eumorphia (http://empress.har.mrc.ac.uk)
(Kastenberger et al., 2012a; Kastenberger et al., 2012b). Age matched
mice were tested in a ﬁxed testing schedule with intervals of one
week between open ﬁeld, elevated plus maze, light dark test and tail
suspension test. The forced swim test was performed after a break of
3 weeks as a ﬁnal test.
Mice that underwent the physical exam were not included in the
tests for anxiety and stress coping behavior. Mice used for breeding or
daily investigations of the estrous cycle were not behaviorally tested.
For behavioral tests, the estrous stage of the female mice was deter-
mined once immediately after each test by analysis of vaginal smear
to avoid additional stress to the animals and any inﬂuence on their
estrous cyclicity and testing results.
Every test was videotaped and evaluated using the TSE (Bad
Homburg, Germany) VideoMot 2 System (OF, EPM, LDT), or manually
by an experimenter blinded to the genotype and treatment (TST, FST)
of each mouse. In between and prior to each test, the equipment was
cleaned with 10% ETOH.Vaginal smear evaluation
Immediately after each behavioral test, smears were taken from
each female mouse by vaginal lavage with 50 μl saline. The smear was
analyzed under an axiophot optical microscope (Carl Zeiss AG,
Göttingen, Germany) and dried. Diestrus (also called diestrus II) smears
were mainly leucocytic, with some single, round, nucleated epithelial
cells. Pro-estrus smears consisted of leukocytes and clumps of nucleated
epithelial cells. In estrus smears, denucleated cells with jagged edges
and corniﬁed, needle like cells were present. Met-estrus (also called
diestrus I), as an intermediate state, consisted of denucleated cells,
leucocytes and also sometimes round, nucleated cells. Dried smears
were ﬁxed for 10 min in methanol and stained for 45 min in diluted
GIEMSA solution (Fa. Roth, Karlsruhe, Germany, Art No. T862.1, diluted
1:20 in distilled water), washed with distilled water and cover slipped
(EUKITT, O. Kindler GmbH, Freiburg, Germany) for storage and micro-
scopic analysis.Open ﬁeld test (OF)
The OF test was performed on behaviorally testing naive mice,
as it was the ﬁrst test in the testing battery. The test apparatus was a
50 × 50 cm synthetic box. The arena was divided into 3 areas. The bor-
der area was 8 cm distance from the wall, the center (20 × 20 cm) cov-
ered 16% of the total area, and the area in betweenwas the intermediate
zone. Illuminationwas set to 150 lx in the center of the OF.When tested,
eachmousewas placed in themiddle of the OF and recorded for tenmi-
nutes. The time the mouse spent there, the distance traveled and the
number of visits to the center of the OF were taken as measures of
trait anxiety levels.
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The EPM consisted of 4 arms, forming the shape of a plus, elevated
70 cm above the ﬂoor. Two opposing arms were closed by black walls,
the other two arms were open. All four arms were connected by a neu-
tral ﬁeld. The dimensions were 30 × 5 cm for the arms, 5 × 5 cm for the
neutral ﬁeld and the framing of the closed arm had a height of 15 cm.
Illumination in the neutral ﬁeld was set to 180 lx. Each mouse was
placed gently on the neutral ﬁeld facing an open arm and allowed to
explore the maze for 5 min. The time spent and distance traveled in
the open arm as well as the number of entries into the open arm were
taken as measures of trait anxiety levels. Closed arm entries were ana-
lyzed for general motor activity.
Light dark test (LDT)
The LDT was performed in the OF arena, modiﬁed with a black box
taking up one third of the space. The illumination in the open area
was set to 400 lx. The mouse was set in front of the entrance to the
black box and was allowed to explore the area for 10 min. Time
spent and distance traveled in the lit area, excluding the transition zone
(5×5 cm in front of the entrance), andnumber of entriesweremeasured.
Tail suspension test (TST)
Mice were ﬁxed with adhesive tape on the tip of their tail to a hori-
zontal metallic bar for 6 min. The light was set to 100 lx in the testing
chamber. Immobility was deﬁned as no active movement but breathing
for at least two seconds and was analyzed from the 2nd to the 6th
minute. Mice who managed to climb up their tail or who fell down
were excluded from the analysis.
Forced swim test (FST)
Two glass cylinders with a diameter of 12 cm and a height of 32 cm
wereﬁlledwith 1.7 l of 25 °Cwarm tapwater directly before the testing.
The water was changed and the cylinders were cleaned after each trial.
The mice were dropped into the water from about 30 cm to duck
their heads. Due to their fast estrous cycling the test was performed in
a single session of 15 min. The behavioral measure scored from the
video was the duration of immobility during the 2nd and 6th minute
(early immobility) and the last 4 min (late immobility). A mouse was
judged to be immobile when making only those movements necessary
to keep its head above water for a minimum of 2 s (ﬂoating). Mice that
were not able to swim (keep their head above the water) for 15 min
were excluded from the analysis.
Stress-induced hyperthermia (SIH)
Mice were allowed to acclimatize to the environment overnight. The
stress-induced hyperthermia test started with the ﬁrst rectal tempera-
turemeasurement (T(1); basal), followed by a second temperaturemea-
surement (T(2)) 10–15min later. The difference DeltaT (=T(2)− T(1))
is the stress-induced hyperthermia (Olivier et al., 2003). Stress-induced
hyperthermiawas tested by inserting a glycerol lubricated anal tempera-
ture probe (Wittmann et al., 2009). Temperature was recordedwhen the
value stabilized (latest after 10 s). Themeasurementwas repeated 30, 60
and 120min. after themeasurement of basal temperature (T1) to analyze
the time-course of the response to restraint.
Serum analysis
For basal corticosterone measurements, animals naïve to testing
were killed between 12:00 and 14:00 o'clock under deep CO2 anesthesia
by decapitation. A vaginal smear was taken immediately after anesthe-
sia to avoid additional stress before sacriﬁce occurred. Trunk blood wascollected into microcentrifuge tubes and kept for one hour at 4 °C. To
obtain serum, blood samples were centrifuged at 1500 rpm for 2 min.
The sera were kept frozen in new microcentrifuge tubes at −20 °C
until analyzed. RIA for corticosterone (MP Biomedicals, Eschwege,
Germany, corticosterone double antibody — 125I RIA Kit, No. 120102)
was performed. Diluted sera were analyzed in duplicate according to
the manufacturers' guidelines.
Statistics
Unless stated otherwise, all data are presented as mean ± SEM and
the number of animals in brackets. To compare the two genotypes the
unpaired t-test was performed.
To compare more than 2 groups with a single genotype, 1 way
ANOVA with Bonferroni multiple comparison or Dunnett's post-hoc
test was performed.
Different groups with different genotypes were analyzed by 2 way
ANOVA followed by a Bonferroni multiple comparison test.
A p-value less than 0.05was considered to be statistically signiﬁcant.
All data were analyzed as described by graph pad PRISM 5 for Mac
OS X, version 5.0a.
Results
There were no obvious differences in fertility, body weight, sensory
function, fur, whisker condition or estrous smear histology observed be-
tweenWT and GPER1-KOmice. Estrous cycle length measurements re-
vealed no differences between GPER1-KO and WT mice (WT 6.35 ±
1.4 days and GPER1-KO 6.41 ± 1.6 days).
No differencewas observed regarding breeding rates. The number of
litters, in one year, of GPER1-KO was indistinguishable from WT mice
(GPER1-KO 6.7 ± 2.1 pups per litter, N = 14 litters; WT 7.5 ± 3.3
pups per litter, N = 14 litters; t-test p = 0.49).
Basic behavior in the home cagewas normal, without excessive run-
ning, jumping or cycling. In addition, when performing the wire hang
test, both genotypes were able to hold themselves for a minimum of
two minutes on the wire without falling or jumping down.
In the home cage (HC; Fig. 1), GPER1-KO males showed increased
overall activity (2 way ANOVA, F1,1862 = 49.15; p b 0.0001), which
was mainly due to increased activity during the ﬁrst night (WT
9737 ± 3143 arbitrary activity counts (AAC), N = 8 vs. GPER1-KO
15,664 ± 5762 AAC, N = 8; unpaired t-test p b 0.0229, 2 way ANOVA
p b 0.01, Genotype effect F = 6.452, time F = 7.422; Fig. 1A), which
lost statistical signiﬁcance in the second night (WT 8373 ± 3311 AAC
vs. GPER1-KO 10,116 ± 2852 AAC) and was no longer detected by the
third night (WT 7626 ± 3509 AAC vs. GPER1-KO 8042 ± 2565 AAC).
Ambulation was signiﬁcantly higher during the ﬁrst night as compared
to the second or third night (1wayANOVA; F= 5.239; Bonferroni post-
hoc test, ﬁrst vs. second night p b 0.05, ﬁrst vs. third night p b 0.01) in
GPER1-KO, but not WT mice. During daytime there was no difference
between the genotypes in activity counts (ﬁrst day WT 1799 ± 909
AAC vs. GPER1-KO 1611 ± 767 AAC; second day WT 1838 ± 398 AAC
vs. GPER1-KO 1935 ± 905 AAC).
In females, WT mice were more active than GPER1-KO mice
(F1,1778 = 86.70; p b 0.0001). This was observed mainly at night,
with a statistically signiﬁcant difference during the second night (WT
17,488 ± 8148 AAC, N = 9 vs. GPER1-KO 10,635 ± 4971 AAC, N = 7,
2 way ANOVA; F1,42 = 7.95; p = 0.0073; Fig. 1B). As in the males, the
activity of female GPER1-KO mice was indistinguishable from that of
female WT mice during the daytime (WT 2433 ± 1383 AAC, N = 9 vs.
GPER1-KO 1560 ± 806 AAC, N = 7, n.s.). Comparing the two sexes,
female WT were more active than male WT mice during the night
(18,137 ± 7549; 17,488 ± 8148; 14,285 ± 7549 AAC for the ﬁrst, sec-
ond and third night of WT (N = 9), respectively vs. 9736 ± 3143;
8372 ± 3311; 7626 ± 3509 for GPER1-KO (N = 7) 2 way ANOVA
Fig. 1.Homecage (HC) activity ofmale (A) and female (B)WT (black) andGPER1-KO(gray)mice. The left graphs display the circadian rhythmicity ofHC activity ofmale (upperpanel) and
female (lower panel)WT and GPER1mice. The bar graphs represent cumulative activities of male and femaleWT (open bars) and GPER1-KO (shaded bars)mice during three consecutive
nights. Data represent mean ± SEM; AAC = arbitrary activity counts. Statistical analysis was done by 1 way ANOVA with Bonferroni post-hoc test: *p b 0.05; **p b 0.01; 2 Way ANOVA
with Bonferroni posttest: #p b 0.05. Numbers in bars represent N of animals in testing groups.
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GPER1-KO mice (F1,39 = 0.8448)
During the ﬁrst 3 h of the HC (novelty), AAC of males and females
were comparable (male WT 3639 ± 1044 AAC, N = 8; male GPER1-
KO 4331 ± 1354 AAC, N = 8; female WT 4731 ± 2509 AAC, N = 9;
female GPER1-KO 3426 ± 2290 AAC, N = 7).Fig. 2. Time spent in the center area (left column), distance traveled in the center (middle colum
for male (A) and female (B) WT (open bars) and GPER1 KO (shaded bars) mice. Data repres
###p b 0.001. Di = diestrus state; pro = pro-estrus state; est = estrus state. Numbers in barAnxiety related behavior in male GPER1-KO mice
In the OF test we did not observe any difference between WT
and GPER1-KO mice regarding time spent (WT 43 ± 6 s, N = 11 vs.
GPER1-KO 43 ± 5 s, N = 15) or distance traveled (% of total distance
WT 11 ± 1% vs. GPER1-KO 11 ± 0.6%) in the center of the OFn) and entries into the center (right column) during the open ﬁeld (OF) test are depicted
ent mean ± SEM; 2 way ANOVA with Bonferroni post-hoc test: #p b 0.05; ##p b 0.01;
s represent N of animals in testing groups.
Fig. 3. Time spent (left column), distance traveled on the open arm (middle column) and entries into the open arm (right column) during the elevated plus maze (EPM) test are
depicted for male (A) and female (B) WT (open bars) and GPER1 KO (shaded bars) mice. Data represent mean ± SEM. Statistical comparisons in A were done by unpaired t-test
(*p b 0.05). Di = diestrus state; pro = pro-estrus state; est = estrus state. Numbers in bars represent N of animals in testing groups.
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between the genotypes (WT 27 ± 3 vs. GPER1-KO 26 ± 2).
In the EPM (Fig. 3A) we observed increased ambulation of the open
arms in the GPER1-KOmice compared with WT mice. This was statisti-
cally signiﬁcant regarding time spent in the open arm (WT 7± 2 s, N=
13 vs. GPER1-KO 14 ± 3 s, N = 9, unpaired t-test p = 0.0352,) and the
distance traveled (WT 2±1%of total distance vs. GPER1-KO5±1%, un-
paired t-test p= 0.0228). No difference was observed in the number ofFig. 4. Time spent (left column), distance traveled (middle column) and entries into the lighted
female (B) WT (open bars) and GPER1 KO (shaded bars) mice. Data represent mean ± SEM. S
2 way ANOVA with Bonferroni post-hoc test # p b 0.05. Di = diestrus state; pro = pro-estrusclosed arm entries (WT 14 ± 1 vs. GPER1-KO 15 ± 2), suggesting that
overall motor activity was not altered between the genotypes.
In the LDT (Fig. 4A) we observed a statistically signiﬁcant difference
between WT and GPER1-KO mice in the time spent in the lit area
(WT 105 ± 23 s, N = 14 vs. GPER1-KO 201 ± 44 s, N = 10, unpaired
t-test p = 0.0481), but not for the distance traveled (WT 394 ±
50 cm vs. GPER1-KO 527 ± 88 cm) or visits to the lit area (WT 10 ± 2
vs. GPER1-KO 14 ± 3).area (right column) during the light–dark choice (LD) test are depicted for male (A) and
tatistical comparisons in A were done by unpaired t-test (*p b 0.05), and in B by applying
state; est = estrus state. Numbers in bars represent N of animals in testing groups.
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Female micewere analyzed as an entire group aswell as sub-groups
at different estrous stages. Only minor differences were observed be-
tween female WT and GPER1-KO mice in the OF. Thus, only during es-
trus, GPER1-KO mice displayed higher exploratory drive than WT
animals in the center area (WT: di 53 ± 6.0 (N = 10); pro 46 ± 7.4
(N = 8); est 38 ± 6.4 (N = 9) s vs. GPER1-KO: di 47 ± 12.6 (N = 8);
pro 48 ± 12.6 (N = 8); est 48 ± 6.2 (N = 14) s; 2 way ANOVA with
Bonferroni post-hoc test p b 0.05; interaction F2,51 = 4.17, estrous
stage F2,51 = 3.26). However, this was apparently due to reduced ex-
ploratory drive in WT mice during this estrous stage, rather than to an
increased drive in GPER-KO mice (Fig. 2B). No differences were ob-
served in the EPM (Fig. 3B) and LDT (Fig. 4B).Stress related behavior in male GPER1 KO mice
In the TST no difference in immobility time was observed between
male WT and GPER1-KO mice (WT 57 ± 12 s, N = 14 and GPER1-KO
70 ± 14 s, N = 14, unpaired t-test p = 0.6239; Fig. 5A).
In the FST (Fig. 5C) no difference was observed in the early immobil-
ity time (2nd to 6th minute) (GPER1-KO 140 ± 22 s, N = 6 vs. WT
101 ± 39 s, N = 8) or in the last 5 min of the 15-minute trial (GPER1-
KO 151 ± 58 s, N = 6 vs. WT 163 ± 34 s, N = 8). However, there was
a signiﬁcant difference between early and late immobility in WT, but
not GPER1-KO mice (2-way ANOVA: WT p b 0.01, GPER1-KO p N 0.05;
F1,24 = 12.98)
Stress-induced hyperthermia revealed comparable basal tempera-
ture and initial increases inWT and GPER1-KOmice (Fig. 6C). Notewor-
thy, the temperature in WT mice had returned to basal after 60 min,
while it was still signiﬁcantly increased in GPER1-KO mice at this
time-point. Still, there was no statistical difference between genotypes
at any time-interval.Fig. 5. Immobility time (2nd to 6th minute) measured during tail suspension tests (TST) on m
the upper panel. Note the inverse results for female mice along the estrous cycle. For the forc
times are displayed for male (C) and female (D) mice. Data represent mean ± SEM; Di =
ANOVA with Bonferroni post-hoc test. Numbers in bars represent N of animals in testing groupStress related behavior in female GPER1 KO mice
In the TST, female WT mice showed a reduced immobility time
in pro-estrus compared to diestrus (pro-estrus 48 ± 23 s, N = 6 vs.
diestrus 101 ± 49 s, N = 9, 2 way ANOVA p b 0.05; F2,50 = 2.407).
In contrast, GPER1-KO mice showed reduced immobility time in dies-
trus (diestrus 41 ± 27 s, N = 9 vs. estrus 100 ± 35, N = 13, 2 way
ANOVA;p b 0.01, F2,50 = 4.861), resulting in a signiﬁcant difference
between WT and GPER1-KO mice in the diestrus states (2 way
ANOVA; Interaction F2,50 = 5.02; p b 0.0103).
In the FST no difference regarding estrous state or timewas observed
in GPER1-KO mice. However, WT mice had a statistically signiﬁcant in-
crease in immobility time in the last 5 min of the trial compared to the
ﬁrst minutes (WT diestrus early 124 ± 24 s, N = 7 vs. WT diestrus
late 190± 33 s, N= 7,WT estrus early 124± 50 s, N= 7 vs. WT estrus
late 183±35 s, N=7, 2way ANOVA, F3,84= 6.120, both p b 0.05). This
results in an overall signiﬁcant inﬂuence of time (2-way ANOVA,
F3,84 = 6.120, p = 0.0008). Moreover, we observed a signiﬁcant differ-
ence betweenWTandGPER1-KOmice in early immobility during estrus
(WT estrus early 124 ± 50 s, N = 7 vs. GPER1-KO estrus early 175 ±
39 s, N = 13, 2 way ANOVA, p b 0.05) Three WT mice (two pro-estrus
state, one estrous state) were not able to swim for 15 min and were
excluded from the analysis.
During the test for stress-induced hyperthermia, we observed
higher basal body temperature in female mice as compared to male
mice; however, temperatures were comparable between WT and
GPER1-KO mice (Fig. 6D). In females, the initial increase was less pro-
nounced than inmalemice, but followedby a late decrease in body tem-
perature. The temperature in WT mice was signiﬁcantly increased
10 min after measuring basal temperature and reduced after 60 min.
In contrast, GPER1-KO mice displayed a delayed increase, reaching
statistical signiﬁcance at the 30 min interval, and a delayed subsequent
decrease lacking signiﬁcance at the 60 min interval (Fig. 6D). However,
no difference between genotypes was observed at any time-point.ale (A) and female (B) WT (open bars) and GPER1-KO (shaded bars) mice are shown in
ed swim test (FST) early (2nd to 6th minute) and late (11th to 15th minute) immobility
diestrus state; pro = pro-estrus state; est = estrus state; *p b 0.05; **p b 0.01; 2 way
s.
Fig. 6. Corticosterone levels in male (A) and female (B) WT (open bars) and GPER1-KO (shaded bars) mice were measured by RIA. Note the antidromic elevation in female WT and KO
mice. Stress-induced hyperthermia was measured after 10, 30, 60, and 120 min. Data for male (C) and female (D) WT and GPER1-KO mice are depicted. Note the prolonged increase
in stress response in male GPER1-KO mice. Mean ± SEM. Di = diestrus state; pro = pro-estrus state; est = estrus state; mean ± SEM; 2 way ANOVA with Bonferroni post-hoc test
#p b 0.05; ##p b 0.01; ###p b 0.001; 1 way ANOVA with Dunnetts's Multiple Comparison Test *p b 0.05. Numbers in bars represent N of animals in testing groups.
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Corticosterone levels were measured in male and female GPER1-
KO and WT mice. Male mice did not show differences in their basal
corticosterone levels (WT 123 ± 17 ng/ml, N = 5 vs. GPER1-KO
147 ± 32 ng/ml, N = 5, Fig. 6A). The basal corticosterone levels in
female GPER1-KO mice did not differ from WT mice when all mice
were pooled (WT 182 ± 34 ng/ml, N = 15 vs. GPER1-KO 189.3 ±
30.8 ng/ml, N= 15). In contrast, analysis of corticosterone levels accord-
ing to the estrous cycle (Fig. 6B) showed thatWTmice had an increase in
corticosterone in pro-estrus (WT diestrus 66 ± 54 ng/ml, N = 5, vs. WT
pro-estrus 302 ± 113 ng/ml, N = 5, p b 0.01, 1 way ANOVA; WT pro-
estrus 302 ± 113 ng/ml, N = 5 vs. WT estrus 148 ± 59 ng/ml, N = 5,
p b 0.05, 1 way ANOVA; F = 11.05; 2 way ANOVA, Interaction F2,24 =
19.97 p b 0.0001), whereas GPER1-KO mice showed a decrease in pro-
estrus compared to diestrus mice (KO diestrus 308 ± 66 ng/ml, N = 5
vs. KO pro-estrus 84 ± 42 ng/ml, N = 5, p b 0.01, 1 way ANOVA;
F = 10.48). There was a signiﬁcant difference between GPER1-KO
diestrus and WT diestrus mice (308 ± 66 ng/ml, N = 5 vs. 66 ±
54 ng/ml, N = 5, 2 way ANOVA, p b 0.001) and GPER1-KO pro-estrus
and WT pro-estrus mice (84 ng/ml ± 42, N = 5 vs. 302 ng/ml ± 113,
N = 6).Discussion
Our data obtained from behavioral testing revealed a phenotype of
sex and paradigm dependent reduced anxiety-like behavior and altered
stress response in GPER1-KO mice. Alterations in anxiety-like behavior
were observed predominantly in male mice, while alterations in stress
response were observed in females. The main observation was a shift
in the cycle-dependent ﬂuctuations of basal corticosterone levels and
stress coping in female GPER1-KO mice. The length of the estrous
cycle and duration of the different stages was comparable between
GPER1-KO andWT C57BL/6J mice. In any case, cycle lengths were com-
parable to observations in a longitudinal study of estrous cyclicity in
aging C57BL/6J mice (Nelson et al., 1982).Increased exploratory drive in the GPER1-KO is in line with the
anxiogenic effects observed after treatment of male mice with either
17β-est or G1 in our previous study (Kastenberger et al., 2012b). The
phenotype of reduced anxiety like behavior was mainly observed in
the test with higher aversiveness of the exposed area (EPM and LDT)
than in the OF, suggesting that increased stress during the test plays a
role. In line with this, WT mice displayed signiﬁcantly less immobility
in the early stage of the FST. High activity in the ﬁrst minutes is often
a sign of anxiety. Still, the effects observed on the C57BL/6N background
in the recent pharmacological study (Kastenberger et al., 2012b) were
more clear-cut than the effects observed in the germ-line KO mice on
the C57BL/6J background used in this study. This may, at least in part,
be due to the known differences in anxiety-like behavior between
these two strains (Matsuo et al., 2010; Simon et al., 2013). In contrast
to C57BL/6N mice, female C57BL/6 J mice used in this study displayed
negligible alterations in exploratory behavior along their estrous cycle.
Thus, direct implications of altered estrogen levels on alterations in be-
havior could not be assessed in these animals. In line with alterations in
anxiety during the menstrual cycle in human beings (Toufexis et al.,
2006), alterations in anxiety-related tests were also reported for female
rodents (Frye et al., 2000; Marcondes et al., 2001; Morgan and Pfaff,
2002).While anxiety levels appeared to be lower during late pro-estrus
and estrus, indicators of increased anxietywere observed during late di-
estrus/early pro-estrus, the time of rising estrogen in female mice and
rats. It was suggested that these mood changes might be due to the an-
xiolytic effects of larger amounts of estrogen,which are preceded by the
anxiogenic effects of ﬂuctuations in estrogen levels (Toufexis et al.,
2006). However, alterations in anxiety and responsiveness to mild
anxiogenic stress in diestrus, compared to pro-estrus and estrus, appear
highly divergent in both rats andmice (Mora et al., 1996; Ho et al., 2001;
Marcondes et al., 2001; Hiroi and Neumaier, 2006). In any case, our
present data support the idea that the G1-induced anxiogenic effects
in C57BL/6 N mice are indeed GPER1-mediated.
We observed an interesting phenotype regarding the behavior of
mice in their home cages. It is known that female mice are more active
than male mice, which has been suggested to be related to the higher
estrogen levels in females (for a review see (Walf and Frye, 2006)). In
635I. Kastenberger, C. Schwarzer / Hormones and Behavior 66 (2014) 628–636fact, ovariectomized femalemice displayed strongly reduced home cage
activity (Kastenberger et al., 2012b). Sex differences in home cage activ-
ity were also observed in this study (55,500 ± 7500 in females vs.
30,700 ± 3500 total activity counts over three nights, two days in
males). Noteworthy, GPER1-deﬁciency induced increased activity in
males, but decreased activity in female mice, completely abolishing
the difference (39,200± 6100 in females vs. 39,400± 3200 total activ-
ity counts over three nights, two days in males). Thus, considering
GPER1 as an estrogen receptor, it could be involved in the locomotive
actions of estrogen in females. In contrast, males displayed increased
motor activity when they were deﬁcient for GPER1. In addition, there
were clear differences between the three subsequent nights of home
cage activity testing. The genotype differences were most pronounced
during the ﬁrst night, when the cage was novel. Exploration of a novel
environment strongly involves the hippocampus, an area known to be
heavily inﬂuenced by estrogen (for review see (McEwen et al., 2012))
and to express GPER1 (Hazell et al., 2009; Akama et al., 2013).
Apparently, GPER1 mediates several effects, which sum up to differ-
ent net-effects in female and male mice. Such differences may depend
on higher estrogen levels and resulting differences in activation of dif-
ferent estrogen receptors. It is tempting to speculate that there might
be a reduction in anxiety paralleled by a reduction in motor activity in
GPER1-KOmice.With low estrogen, higher anxiety and lowermotor ac-
tivity levels – as in males – the sum of the effects reveals an anxiolytic-
like phenotype. In contrast, with higher estrogen and high basal motor
activity, but lower trait anxiety – i.e. in females – reduced anxiety
does not translate intomeasurable differences under normal conditions.
Yet, under basal conditions the reducedmotor drivewill be themain ef-
fect measured. Importantly, no signiﬁcant differences in total distance
traveled were observed between genotypes during behavioral testing.
In the tail suspension test, no differences between genotypes were
observed in male mice. The results obtained from female mice in this
test revealed marked differences between GPER1-KO and WT mice in
the diestrus stage. Differences between the sexes in stress response,
with a stronger inﬂuence of vasopressin, ACTH and corticosterone on
the HPA axis in females, was proposed based on studies in rodents
(for a review see ter Horst et al., 2012). Such a difference at low estrogen
levels is not supported by the data obtained from the forced swim test,
and also not by the data obtained from male mice. Measurement of
basal corticosterone levels revealed, that at stageswith lowest immobil-
ity (pro-estrus inWT and diestrus in GPER1-KO), basal corticosterone is
highest. As observed in WT mice, rodents usually display an increase in
corticosterone during the pro-estrus and estrus phase (Rodrigues et al.,
1995; Atkinson andWaddell, 1997). Also, the high levels of basal serum
corticosterone measured were in line with the literature (Rodrigues
et al., 1995). GPER1-KO mice contrast this by displaying increased
basal corticosterone levels during diestrus and the lowest basal levels
during pro-estrus. Noteworthy, pooling the data of all female mice test-
edwithout separating the estrous cycle stages results in unaltered stress
behavior and corticosterone levels.
The results regarding stress induced hyperthermia revealed
minor alterations in the GPER1-KO mice. If there was a difference at
all, it was a potentially prolonged stress response observed in stress-
induced hyperthermia consistent between the two sexes. The early re-
sponse (increase after 10 min) is comparable between genotypes,
which is in line with the lack of difference observed in male mice in
the tail suspension and forced swim tests and in females in the forced
swim test. The higher basal temperature and resulting less pronounced
stress-induced increase in female mice is in line with the literature
(Sanchez-Alavez et al., 2011).
Overall, our data indicate that GPER1 is involved in sex steroid depen-
dent stress and corticosterone-level control, thereby supporting the hy-
pothesis that GPER1 indeed represents an estrogen receptor. However,
the mechanism(s) involved appear complex and may well involve
counteracting mechanisms in the hypothalamus and hippocampus as
well as the spinal cord. Moreover, GPER1 is involved in anxiety-likebehavior; however, without displaying any clear estrogen dependency
of these effects. Thus, our data provide clear evidence for a functional
role of GPER1, but to understand the complex nature of this involvement
further experiments are needed. These experiments should focus on the
functional role of GPER1 in distinct brain nuclei and therefore depend
on the generation of new tools like conditional GPER1 KO mice.
Acknowledgments
The authors want to thank Christa Stichlberger for excellent techni-
cal assistance. This work was supported by the Austrian Science Fund,
Project I-977. The funding body did not take any inﬂuence on this study.
References
Akama, K.T., Thompson, L.I., Milner, T.A., McEwen, B.S., 2013. Post-synaptic density-95
(psd-95) binding capacity of g-protein-coupled receptor 30 (gpr30), an estrogen
receptor that can be identiﬁed in hippocampal dendritic spines. J. Biol. Chem. 288,
6438–6450.
Atkinson, H.C., Waddell, B.J., 1997. Circadian variation in basal plasma corticosterone and
adrenocorticotropin in the rat: sexual dimorphism and changes across the estrous
cycle. Endocrinology 138, 3842–3848.
Boulware, M.I., Mermelstein, P.G., 2005. The inﬂuence of estradiol on nervous system
function. Drug News Perspect. 18, 631–637.
Brailoiu, E., Dun, S.L., Brailoiu, G.C., Mizuo, K., Sklar, L.A., Oprea, T.I., Prossnitz, E.R., Dun, N.J.,
2007. Distribution and characterization of estrogen receptor g protein-coupled recep-
tor 30 in the rat central nervous system. J. Endocrinol. 193, 311–321.
Brinton, R.D., Thompson, R.F., Foy, M.R., Baudry, M., Wang, J., Finch, C.E., Morgan, T.E., Pike,
C.J., Mack, W.J., Stanczyk, F.Z., Nilsen, J., 2008. Progesterone receptors: form and
function in brain. Front. Neuroendocrinol. 29, 313–339.
Dennis, M.K., Burai, R., Ramesh, C., Petrie, W.K., Alcon, S.N., Nayak, T.K., Bologa, C.G.,
Leitao, A., Brailoiu, E., Deliu, E., Dun, N.J., Sklar, L.A., Hathaway, H.J., Arterburn, J.B.,
Oprea, T.I., Prossnitz, E.R., 2009. In vivo effects of a gpr30 antagonist. Nat. Chem. Biol.
5, 421–427.
Frye, C.A., Petralia, S.M., Rhodes, M.E., 2000. Estrous cycle and sex differences in perfor-
mance on anxiety tasks coincide with increases in hippocampal progesterone and
3alpha,5alpha-thp. Pharmacol. Biochem. Behav. 67, 587–596.
Hammond, R., Gibbs, R.B., 2011. Gpr30 is positioned to mediate estrogen effects on basal
forebrain cholinergic neurons and cognitive performance. Brain Res. 1379, 53–60.
Hayward, C., Sanborn, K., 2002. Puberty and the emergence of gender differences in
psychopathology. J. Adolesc. Health 30, 49–58.
Hazell, G.G., Yao, S.T., Roper, J.A., Prossnitz, E.R., O'Carroll, A.M., Lolait, S.J., 2009.
Localisation of gpr30, a novel g protein-coupled estrogen receptor, suggests mul-
tiple functions in rodent brain and peripheral tissues. J. Endocrinol. 202, 223–236.
Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M.,
Strom, A., Treuter, E., Warner, M., Gustafsson, J.A., 2007. Estrogen receptors: how do
they signal and what are their targets. Physiol. Rev. 87, 905–931.
Hiroi, R., Neumaier, J.F., 2006. Differential effects of ovarian steroids on anxiety versus
fear as measured by open ﬁeld test and fear-potentiated startle. Behav. Brain Res.
166, 93–100.
Ho, H.P., Olsson, M., Westberg, L., Melke, J., Eriksson, E., 2001. The serotonin reuptake in-
hibitor ﬂuoxetine reduces sex steroid-related aggression in female rats: an animal
model of premenstrual irritability? Neuropsychopharmacology 24, 502–510.
Karl, T., Pabst, R., von Horsten, S., 2003. Behavioral phenotyping of mice in pharmacolog-
ical and toxicological research. Exp. Toxicol. Pathol. 55, 69–83.
Kastenberger, I., Lutsch, C., Herzog, H., Schwarzer, C., 2012a. Inﬂuence of sex and genetic
background on anxiety-related and stress-induced behaviour of prodynorphin-
deﬁcient mice. PLoS ONE 7, e34251.
Kastenberger, I., Lutsch, C., Schwarzer, C., 2012b. Activation of the g-protein-coupled re-
ceptor gpr30 induces anxiogenic effects inmice, similar to oestradiol. Psychopharma-
cology (Berlin) 221, 527–535.
Langer, G., Bader, B., Meoli, L., Isensee, J., Delbeck, M., Noppinger, P.R., Otto, C., 2010.
A critical review of fundamental controversies in the ﬁeld of gpr30 research. Steroids
75, 603–610.
Lebron-Milad, K., Milad, M.R., 2012. Sex differences, gonadal hormones and the fear ex-
tinction network: implications for anxiety disorders. Biol. Mood Anxiety Disord. 2, 3.
Marcondes, F.K., Miguel, K.J., Melo, L.L., Spadari-Bratﬁsch, R.C., 2001. Estrous cycle inﬂu-
ences the response of female rats in the elevated plus-maze test. Physiol. Behav. 74,
435–440.
Matsuo, N., Takao, K., Nakanishi, K., Yamasaki, N., Tanda, K., Miyakawa, T., 2010. Behavior-
al proﬁles of three c57bl/6 substrains. Front. Behav. Neurosci. 4, 29.
McEwen, B.S., Akama, K.T., Spencer-Segal, J.L., Milner, T.A., Waters, E.M., 2012. Estrogen
effects on the brain: actions beyond the hypothalamus via novel mechanisms.
Behav. Neurosci. 126, 4–16.
Mora, S., Dussaubat, N., Diaz-Veliz, G., 1996. Effects of the estrous cycle and ovarian
hormones on behavioral indices of anxiety in female rats. Psychoneuroendocrinology
21, 609–620.
Morgan, M.A., Pfaff, D.W., 2001. Effects of estrogen on activity and fear-related behaviors
in mice. Horm. Behav. 40, 472–482.
Morgan, M.A., Pfaff, D.W., 2002. Estrogen's effects on activity, anxiety, and fear in two
mouse strains. Behav. Brain Res. 132, 85–93.
636 I. Kastenberger, C. Schwarzer / Hormones and Behavior 66 (2014) 628–636Nelson, J.F., Felicio, L.S., Randall, P.K., Sims, C., Finch, C.E., 1982. A longitudinal study of
estrous cyclicity in aging c57bl/6j mice: I. Cycle frequency, length and vaginal cytol-
ogy. Biol. Reprod. 27, 327–339.
Olde, B., Leeb-Lundberg, L.M., 2009. Gpr30/gper1: searching for a role in estrogen physi-
ology. Trends Endocrinol. Metab. 20, 409–416.
Olivier, B., Zethof, T., Pattij, T., van Boogaert, M., van Oorschot, R., Leahy, C., Oosting, R.,
Bouwknecht, A., Veening, J., van der Gugten, J., Groenink, L., 2003. Stress-induced
hyperthermia and anxiety: pharmacological validation. Eur. J. Pharmacol. 463,
117–132.
Otto, C., Fuchs, I., Kauselmann, G., Kern, H., Zevnik, B., Andreasen, P., Schwarz, G., Altmann,
H., Klewer, M., Schoor, M., Vonk, R., Fritzemeier, K.H., 2009. Gpr30 does not mediate
estrogenic responses in reproductive organs in mice. Biol. Reprod. 80, 34–41.
Otto, C., Kantner, I., Nubbemeyer, R., Schkoldow, J., Fuchs, I., Krahl, E., Vonk, R., Schuler, C.,
Fritzemeier, K.H., Erben, R.G., 2012. Estradiol release kinetics determine tissue
response in ovariectomized rats. Endocrinology 153, 1725–1733.
Payne, J.L., 2003. The role of estrogen in mood disorders in women. Int. Rev. Psychiatr. 15,
280–290.
Rodrigues, M.L., Marcondes, F.K., Spadari-Bratﬁsch, R.C., 1995. Relationship among
sensitivity to adrenaline, plasma corticosterone level, and estrous cycle in rats. Can.
J. Physiol. Pharmacol. 73, 602–607.
Sanchez-Alavez, M., Alboni, S., Conti, B., 2011. Sex- and age-speciﬁc differences in core
body temperature of c57bl/6 mice. Age (Dordr) 33, 89–99.
Simon,M.M., Greenaway, S.,White, J.K., Fuchs, H., Gailus-Durner, V., Sorg, T.,Wong, K., Bedu,
E., Cartwright, E.J., Dacquin, R., Djebali, S., Estabel, J., Graw, J., Ingham, N.J., Jackson, I.J.,
Lengeling, A., Mandillo, S., Marvel, J., Meziane, H., Preitner, F., Puk, O., Roux, M., Adams,
D.J., Atkins, S., Ayadi, A., Becker, L., Blake, A., Brooker, D., Cater, H., Champy, M.F.,
Combe, R., Danecek, P., di Fenza, A., Gates, H., Gerdin, A.K., Golini, E., Hancock, J.M.,
Hans, W., Holter, S.M., Hough, T., Jurdic, P., Keane, T.M., Morgan, H., Muller, W., Neff, F.,Nicholson, G., Pasche, B., Roberson, L.A., Rozman, J., Sanderson, M., Santos, L., Selloum,
M., Shannon, C., Southwell, A., Tocchini-Valentini, G.P., Vancollie, V.E., Wells, S.,
Westerberg, H., Wurst, W., Zi, M., Yalcin, B., Ramirez-Solis, R., Steel, K.P., Mallon, A.M.,
Hrab de Angelis, M., Herault, Y., Brown, S.D., 2013. A comparative phenotypic and geno-
mic analysis of c57bl/6j and c57bl/6n mouse strains. Genome Biol. 14, R82.
ter Horst, J.P., de Kloet, E.R., Schachinger, H., Oitzl, M.S., 2012. Relevance of stress and
female sex hormones for emotion and cognition. Cell. Mol. Neurobiol. 32, 725–735.
Tian, Z., Wang, Y., Zhang, N., Guo, Y.Y., Feng, B., Liu, S.B., Zhao, M.G., 2013. Estrogen recep-
tor gpr30 exerts anxiolytic effects bymaintaining the balance between gabaergic and
glutamatergic transmission in the basolateral amygdala of ovariectomized mice after
stress. Psychoneuroendocrinology 38, 2218–2233.
Toufexis, D.J., Myers, K.M., Davis, M., 2006. The effect of gonadal hormones and gender on
anxiety and emotional learning. Horm. Behav. 50, 539–549.
Walf, A.A., Frye, C.A., 2006. A review andupdate ofmechanisms of estrogen in the hippocam-
pus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 31,
1097–1111.
Westberg, L., Eriksson, E., 2008. Sex steroid-related candidate genes in psychiatric disor-
ders. J. Psychiatry Neurosci. 33, 319–330.
Wittmann, W., Schunk, E., Rosskothen, I., Gaburro, S., Singewald, N., Herzog, H.,
Schwarzer, C., 2009. Prodynorphin-derived peptides are critical modulators of anxi-
ety and regulate neurochemistry and corticosterone. Neuropsychopharmacology 34
(3), 775–785 (Feb).
Xu, H., Qin, S., Carrasco, G.A., Dai, Y., Filardo, E.J., Prossnitz, E.R., Battaglia, G., Doncarlos, L.L.,
Muma, N.A., 2009. Extra-nuclear estrogen receptor gpr30 regulates serotonin function
in rat hypothalamus. Neuroscience 158, 1599–1607.
